| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $21.19B | $20.46B | $19.09B |
| YoY Revenue Growth % | +3.6% | +7.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $5.82B | $5.88B | $5.01B |
| Operating Margin % | 27.5% | 28.7% | 26.3% |
| Net Income (GAAP) | $3.48B | $3.13B | $3.07B |
| EBITDA (Normalized) | $7.23B | $7.13B | $5.70B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $6.06B | $6.63B | $5.16B |
| Capital Expenditures (CapEx) | $1.76B | $1.57B | $859.2M |
| Free Cash Flow (FCF) | $4.30B | $5.06B | $4.30B |
| FCF Margin % | 20.3% | 24.7% | 22.5% |
| Return on Invested Capital (ROIC %) | 9.3% | 9.7% | 28.6% |
| Cash & Short-Term Equivalents | $798.0M | $1.24B | — |
| Total Debt (Short + Long Term) | $24.45B | $22.27B | $5.36B |
| Total Stockholders' Equity | $25.79B | $27.07B | $11.00B |